Encore Medical Research of Weston, LLC

Weston, Florida 33331

6 studies enrolling now · 16 studies all time

What they study most

Bone Loss, Change in Bone Mineral Density, Chlamydia, Contraception, Covid19, Epilepsy, Focal Epilepsy, Focal Onset Seizures, Generalized Epilepsy, Gonorrhea, Healthy Volunteer, Nonsegmental Vitiligo

Studies at this site

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• A Study of Zasocitinib in Adults With Nonsegmental Vitiligo — Recruiting now
• Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients — Recruiting now
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Recruiting now
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Running, not enrolling
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
• Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
• Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women — Running, not enrolling
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures — Stopped early
• Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight — Running, not enrolling
• Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight — Running, not enrolling
• Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females — Completed
• Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection — Completed
• Bucillamine in Treatment of Patients With COVID-19 — Stopped early